253 related articles for article (PubMed ID: 24721590)
1. Locoregional recurrence risk for patients with T1,2 breast cancer with 1-3 positive lymph nodes treated with mastectomy and systemic treatment.
McBride A; Allen P; Woodward W; Kim M; Kuerer HM; Drinka EK; Sahin A; Strom EA; Buzdar A; Valero V; Hortobagyi GN; Hunt KK; Buchholz TA
Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):392-8. PubMed ID: 24721590
[TBL] [Abstract][Full Text] [Related]
2. Minimal impact of postmastectomy radiation therapy on locoregional recurrence for breast cancer patients with 1 to 3 positive lymph nodes in the modern treatment era.
Miyashita M; Tada H; Suzuki A; Watanabe G; Hirakawa H; Amari M; Kakugawa Y; Kawai M; Furuta A; Sato K; Yoshida R; Ebata A; Sasano H; Jingu K; Ohuchi N; Ishida T
Surg Oncol; 2017 Jun; 26(2):163-170. PubMed ID: 28577722
[TBL] [Abstract][Full Text] [Related]
3. Are there patients with T1 to T2, lymph node-negative breast cancer who are "high-risk" for locoregional disease recurrence?
Mamtani A; Patil S; Stempel MM; Morrow M
Cancer; 2017 Jul; 123(14):2626-2633. PubMed ID: 28334423
[TBL] [Abstract][Full Text] [Related]
4. Most Breast Cancer Patients with T1-2 Tumors and One to Three Positive Lymph Nodes Do Not Need Postmastectomy Radiotherapy.
Muhsen S; Moo TA; Patil S; Stempel M; Powell S; Morrow M; El-Tamer M
Ann Surg Oncol; 2018 Jul; 25(7):1912-1920. PubMed ID: 29564588
[TBL] [Abstract][Full Text] [Related]
5. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
[TBL] [Abstract][Full Text] [Related]
6. [The role of postmastectomy radiotherapy in clinical T1-3N1M0 breast cancer patients with pathological negative lymph nodes after neoadjuvant chemotherapy and mastectomy].
Rong QL; Wang SL; Tang Y; Jin J; Song YW; Wang WH; Liu YP; Fang H; Ren H; Liu XF; Yu ZH; Li YX
Zhonghua Zhong Liu Za Zhi; 2017 Jun; 39(6):445-452. PubMed ID: 28635235
[No Abstract] [Full Text] [Related]
7. Impact of postmastectomy radiation on locoregional recurrence in breast cancer patients with 1-3 positive lymph nodes treated with modern systemic therapy.
Tendulkar RD; Rehman S; Shukla ME; Reddy CA; Moore H; Budd GT; Dietz J; Crowe JP; Macklis R
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e577-81. PubMed ID: 22560546
[TBL] [Abstract][Full Text] [Related]
8. Present-day locoregional control in patients with t1 or t2 breast cancer with 0 and 1 to 3 positive lymph nodes after mastectomy without radiotherapy.
Sharma R; Bedrosian I; Lucci A; Hwang RF; Rourke LL; Qiao W; Buchholz TA; Kronowitz SJ; Krishnamurthy S; Babiera GV; Gonzalez-Angulo AM; Meric-Bernstam F; Mittendorf EA; Hunt KK; Kuerer HM
Ann Surg Oncol; 2010 Nov; 17(11):2899-908. PubMed ID: 20443145
[TBL] [Abstract][Full Text] [Related]
9. Postmastectomy Radiation Therapy in Women with T1-T2 Tumors and 1 to 3 Positive Lymph Nodes: Analysis of the Breast International Group 02-98 Trial.
Zeidan YH; Habib JG; Ameye L; Paesmans M; de Azambuja E; Gelber RD; Campbell I; Nordenskjöld B; Gutiérez J; Anderson M; Lluch A; Gnant M; Goldhirsch A; Di Leo A; Joseph DJ; Crown J; Piccart-Gebhart M; Francis PA
Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):316-324. PubMed ID: 29534902
[TBL] [Abstract][Full Text] [Related]
10. Do Recent Advances in Diagnostic and Therapeutic Procedures Negate the Benefit of Postmastectomy Radiotherapy in N1 Patients With a Low Risk of Locoregional Recurrence?
Chang JS; Lee J; Kim KH; Sohn JH; Kim SI; Park BW; Chung HC; Keum KC; Suh CO; Kim YB
Medicine (Baltimore); 2015 Aug; 94(33):e1259. PubMed ID: 26287410
[TBL] [Abstract][Full Text] [Related]
11. Locoregional recurrence risk factors in breast cancer patients with positive axillary lymph nodes and the impact of postmastectomy radiotherapy.
Nagao T; Kinoshita T; Tamura N; Hojo T; Morota M; Kagami Y
Int J Clin Oncol; 2013 Feb; 18(1):54-61. PubMed ID: 22068463
[TBL] [Abstract][Full Text] [Related]
12. Selection criteria for postmastectomy radiotherapy in t1-t2 tumors with 1 to 3 positive lymph nodes.
Moo TA; McMillan R; Lee M; Stempel M; Patil S; Ho A; El-Tamer M
Ann Surg Oncol; 2013 Oct; 20(10):3169-74. PubMed ID: 23975289
[TBL] [Abstract][Full Text] [Related]
13. Patterns and risk factors of locoregional recurrence in T1-T2 node negative breast cancer patients treated with mastectomy: implications for postmastectomy radiotherapy.
Abi-Raad R; Boutrus R; Wang R; Niemierko A; Macdonald S; Smith B; Taghian AG
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e151-7. PubMed ID: 21420245
[TBL] [Abstract][Full Text] [Related]
14. Post-mastectomy radiotherapy for women with early breast cancer and one to three positive lymph nodes.
Verma R; Chandarana M; Barrett J; Anandadas C; Sundara Rajan S
Cochrane Database Syst Rev; 2023 Jun; 6(6):CD014463. PubMed ID: 37327075
[TBL] [Abstract][Full Text] [Related]
15. Local-regional recurrence with and without radiation therapy after neoadjuvant chemotherapy and mastectomy for clinically staged T3N0 breast cancer.
Nagar H; Mittendorf EA; Strom EA; Perkins GH; Oh JL; Tereffe W; Woodward WA; Gonzalez-Angulo AM; Hunt KK; Buchholz TA; Yu TK
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):782-7. PubMed ID: 21885207
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of postoperative radiotherapy in patients with breast cancer and with pT1-2 and 1-3 lymph node metastases: A retrospective cohort study based on the Japanese Breast Cancer Registry.
Yamada A; Hayashi N; Kumamaru H; Nagahashi M; Usune S; Asaga S; Iijima K; Kadoya T; Kojima Y; Kubo M; Miyashita M; Miyata H; Ogo E; Tamura K; Tanakura K; Tada K; Niikura N; Yoshida M; Ohno S; Ishikawa T; Narui K; Endo I; Imoto S; Jinno H
Eur J Cancer; 2022 Sep; 172():31-40. PubMed ID: 35752154
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors for breast cancer patients with T1-2 tumors and 1-3 positive lymph nodes and the role of postmastectomy radiotherapy in these patients.
Zhao JM; An Q; Sun CN; Li YB; Qin ZL; Guo H; Zeng X; Zhang YT; Wei LL; Han N; Sun SC; Zhang N
Breast Cancer; 2021 Mar; 28(2):298-306. PubMed ID: 32940902
[TBL] [Abstract][Full Text] [Related]
18. Locoregional Recurrence Risk for Postmastectomy Breast Cancer Patients With T1-2 and One to Three Positive Lymph Nodes Receiving Modern Systemic Treatment Without Radiotherapy.
Lai SF; Chen YH; Kuo WH; Lien HC; Wang MY; Lu YS; Lo C; Kuo SH; Cheng AL; Huang CS
Ann Surg Oncol; 2016 Nov; 23(12):3860-3869. PubMed ID: 27436202
[TBL] [Abstract][Full Text] [Related]
19. Impact of postmastectomy radiation therapy in T1-2 breast cancer patients with 1-3 positive axillary lymph nodes.
Yin H; Qu Y; Wang X; Ma T; Zhang H; Zhang Y; Li Y; Zhang S; Ma H; Xing E; Liu X; Xu Q
Oncotarget; 2017 Jul; 8(30):49564-49573. PubMed ID: 28484094
[TBL] [Abstract][Full Text] [Related]
20. The Effect of Adjuvant Trastuzumab on Locoregional Recurrence of Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Treated with Mastectomy.
Lanning RM; Morrow M; Riaz N; McArthur HL; Dang C; Moo TA; El-Tamer M; Krause K; Siu C; Hsu M; Zhang Z; Pei X; McCormick B; Powell SN; Ho A
Ann Surg Oncol; 2015 Aug; 22(8):2517-25. PubMed ID: 25564167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
